Henna: A potential cause of oxidative hemolysis and neonatal hyperbilirubinemia

被引:2
|
作者
Zinkham, WH [1 ]
Oski, FA [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH MED, DEPT PEDIAT, BALTIMORE, MD 21205 USA
关键词
neonatal hyperbilirubinemia; henna; lawsone; glucose-6-phosphate dehydrogenase; oxidative hemolysis;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective. To evaluate the in vitro oxidative potential of lawsone (2-hydroxy-1,4 naphthoquinone). Lawsone is a chemical present in henna, the crushed leaves of which are used worldwide as a cosmetic agent to stain the hair, skin, and nails. Methodology. Venous blood from glucose-6-phosphate dehydrogenase (G6PD)-normal and G6PD A(-) subjects were incubated with various amounts of lawsone for 2 hours at 37 degrees C Reduced glutathione and methemoglobin (MHb) levels were measured before and after incubation. Results. Final molar concentrations of lawsone in normal blood of 1.4, 2.8, 5.7, and 8.6 x 10(-3) mol/L increased MHb percentages from 0.5% to 2.2%, 8.3%, 9.5%, and 12.5%, respectively. In a G6PD A(-) blood, MHb percentages were 19.8%, 32.2%, 44.9%, and 53.9%. At a lawsone concentration of 2.8 x 10(-3) mol/L, blood from 15 healthy adults formed MHb percentages of 7.4% +/- 3.3% (+/-1 SD); in blood from 4 G6PD A(-) adults, percentages were 44.5%, 40.6%, 41.3%, and 42.8%. Simultaneous measurements of reduced glutathione revealed preincubation values of greater than 40 mg/100 mL of red cells in blood of healthy and G6PD A(-) subjects. Postincubation values were greater than 40 in blood of healthy subjects and less than 40 in blood of G6PD A(-) subjects. Conclusions. These in vitro observations indicate that lawsone is an agent capable of causing oxidative hemolysis. In regions of the world where there is a high incidence of G6PD deficiency and unexplained hyperbilirubinemia, oxidative hemolysis secondary to the cutaneous application of henna could be the initiating event.
引用
收藏
页码:707 / 709
页数:3
相关论文
共 50 条
  • [21] Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia
    Lori W. E. van der Schoor
    Henkjan J. Verkade
    Anna Bertolini
    Sanne de Wit
    Elvira Mennillo
    Eva Rettenmeier
    André A. Weber
    Rick Havinga
    Petra Valášková
    Jana Jašprová
    Dicky Struik
    Vincent W. Bloks
    Shujuan Chen
    Andrea B. Schreuder
    Libor Vítek
    Robert H. Tukey
    Johan W. Jonker
    [J]. Scientific Reports, 11
  • [22] Neonatal hyperbilirubinemia and the potential risk of subtle neurological dysfunction
    Bhutani, VK
    [J]. PEDIATRIC RESEARCH, 2001, 50 (06) : 679 - 680
  • [23] Potential of therapeutic bile acids in the treatment of neonatal Hyperbilirubinemia
    van der Schoor, Lori W. E.
    Verkade, Henkjan J.
    Bertolini, Anna
    de Wit, Sanne
    Mennillo, Elvira
    Rettenmeier, Eva
    Weber, Andre A.
    Havinga, Rick
    Valaskova, Petra
    Jasprova, Jana
    Struik, Dicky
    Bloks, Vincent W.
    Chen, Shujuan
    Schreuder, Andrea B.
    Vitek, Libor
    Tukey, Robert H.
    Jonker, Johan W.
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [24] Maternal Cautopyreiophagia as a Rare Cause of Neonatal Hemolysis: A Case Report
    Bernardo, Erika O.
    Matos, Renee I.
    Dawood, Taslim
    Whiteway, Susan L.
    [J]. PEDIATRICS, 2015, 135 (03) : E726 - E729
  • [25] Iron-mediated oxidative cell death is a potential contributor to neuronal dysfunction induced by neonatal hemolytic hyperbilirubinemia
    Viktorinova, Alena
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2018, 654 : 185 - 193
  • [26] NEONATAL HYPERBILIRUBINEMIA
    THALER, MM
    [J]. SEMINARS IN HEMATOLOGY, 1972, 9 (02) : 107 - +
  • [27] NEONATAL HYPERBILIRUBINEMIA
    AASE, JM
    MILBY, TH
    [J]. PEDIATRICS, 1969, 44 (03) : 456 - &
  • [28] NEONATAL HYPERBILIRUBINEMIA
    CASHORE, WJ
    STERN, L
    [J]. PEDIATRIC CLINICS OF NORTH AMERICA, 1982, 29 (05) : 1191 - 1203
  • [29] NEONATAL HYPERBILIRUBINEMIA
    CASHORE, WJ
    [J]. NEW YORK STATE JOURNAL OF MEDICINE, 1991, 91 (11) : 476 - 477
  • [30] NEONATAL HYPERBILIRUBINEMIA
    BRODERSE.R
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1972, 29 : 114 - &